23 July 2015. Link here. First-in-class collaboration combining digital health with class leading inhaled medications Long term international supply agreement targeted at AstraZeneca’s patient support programs Adherium’s Smartinhaler proven to substantially improve medication adherence and health outcomes in adults and children New Zealand-based Adherium (NZ) Limited has entered a long term partnership with international pharmaceutical leader […]
/wp-content/uploads/2018/01/BSM_logo.png00keymaster/wp-content/uploads/2018/01/BSM_logo.pngkeymaster2015-07-23 17:16:162018-01-06 17:16:45Adherium & AstraZeneca Partner to Improve the Lives of Individuals with Respiratory Disease
/wp-content/uploads/2018/01/BSM_logo.png00keymaster/wp-content/uploads/2018/01/BSM_logo.pngkeymaster2015-07-20 17:20:112018-01-06 17:20:44Avita’s ReCell featured in US Army Technology Magazine
20 July 2015, link here. Rex Bionics Plc (AIM: RXB), the pioneer of the REX Robot technology that enhances the mobility of wheel-chair users, is pleased to announce that it has today signed a new agreement for a partnership in China with MAAB Group, an investment and trading company that specialises in sourcing and introducing innovative […]
/wp-content/uploads/2018/01/BSM_logo.png00keymaster/wp-content/uploads/2018/01/BSM_logo.pngkeymaster2015-07-20 17:17:382018-01-06 17:18:06Avita Medical Announces Financial Results and Provides Corporate Update for Fourth Quarter and Fiscal Year 2015
DUBLIN, Ireland, July 7, 2015 (GLOBE NEWSWIRE) — Link here. Nexvet Biopharma (Nasdaq:NVET), a veterinary biologics developer, today announced the signing of a research and development agreement with leading Japanese animal health company Zenoaq (Nippon Zenyaku Kogyo Co., Ltd.) to develop a number of therapeutic biologics for companion animals. The biologics will target undisclosed proteins involved […]
/wp-content/uploads/2018/01/BSM_logo.png00keymaster/wp-content/uploads/2018/01/BSM_logo.pngkeymaster2015-07-07 17:20:542018-01-06 17:21:25Nexvet and Zenoaq Enter Research and Development Collaboration
/wp-content/uploads/2018/01/BSM_logo.png00keymaster/wp-content/uploads/2018/01/BSM_logo.pngkeymaster2015-07-06 17:22:082018-01-06 17:33:53Avita Medical – Data Demonstrating ReCell® Effectiveness in Skin Repigmentation Published in Journal of the American Academy of Dermatology
SEA: NZX and Media Release 29 June 2015. Link here. Board reduced to five with focus on supply chain and production; outgoing CEO named Honorary President SeaDragon Limited (NZX:SEA) today announces a number of Director changes as it adds production and supply chain management experience to the Board in preparation for the company’s move into the […]
9:53am, 24 Jun 2015 SEA: NZX and Media Release 24 June 2015 Link here. SeaDragon raises up to $2.5M with convertible loan; signals capital raising Richard Alderton appointed Interim Chief Executive Officer SeaDragon Limited (NZX:SEA) today announces that one of its cornerstone shareholders, BioScience Managers, has agreed to advance the company up to NZ$2.5 million via […]
/wp-content/uploads/2018/01/BSM_logo.png00keymaster/wp-content/uploads/2018/01/BSM_logo.pngkeymaster2015-06-24 17:35:252018-01-06 17:36:00SeaDragon raises up to $2.5M with convertible loan
Adherium & AstraZeneca Partner to Improve the Lives of Individuals with Respiratory Disease
/in Adherium, Portfolio Companies23 July 2015. Link here. First-in-class collaboration combining digital health with class leading inhaled medications Long term international supply agreement targeted at AstraZeneca’s patient support programs Adherium’s Smartinhaler proven to substantially improve medication adherence and health outcomes in adults and children New Zealand-based Adherium (NZ) Limited has entered a long term partnership with international pharmaceutical leader […]
Avita Medical Shareholder Update
/in Avita Medical, Portfolio Companies22 July 2015 – link here. Letter from the CEO.
Avita’s ReCell featured in US Army Technology Magazine
/in Avita Medical, Portfolio Companies20 July 2015. Link here.
Rex Bionics plc – Announcement of partnership agreement with MAAB
/in Portfolio Companies, Rex Bionics20 July 2015, link here. Rex Bionics Plc (AIM: RXB), the pioneer of the REX Robot technology that enhances the mobility of wheel-chair users, is pleased to announce that it has today signed a new agreement for a partnership in China with MAAB Group, an investment and trading company that specialises in sourcing and introducing innovative […]
Avita Medical Announces Financial Results and Provides Corporate Update for Fourth Quarter and Fiscal Year 2015
/in Avita Medical, Portfolio Companies20 July 2015 – Link here.
Nexvet and Zenoaq Enter Research and Development Collaboration
/in Pharmamark, Portfolio CompaniesDUBLIN, Ireland, July 7, 2015 (GLOBE NEWSWIRE) — Link here. Nexvet Biopharma (Nasdaq:NVET), a veterinary biologics developer, today announced the signing of a research and development agreement with leading Japanese animal health company Zenoaq (Nippon Zenyaku Kogyo Co., Ltd.) to develop a number of therapeutic biologics for companion animals. The biologics will target undisclosed proteins involved […]
Avita Medical – Data Demonstrating ReCell® Effectiveness in Skin Repigmentation Published in Journal of the American Academy of Dermatology
/in Avita Medical, Portfolio Companies6 July 2015. Link here for ASX announcement. Demonstrates 78% Repigmentation compared to 0% in Control Groups.
SeaDragon Annual Report 2014-2015
/in Portfolio Companies, SeaDragon30 June 2015. Link here. SeaDragon annual report, including audited financial statements, for the year to 31 March 2015.
SeaDragon streamlines Board
/in Portfolio Companies, SeaDragonSEA: NZX and Media Release 29 June 2015. Link here. Board reduced to five with focus on supply chain and production; outgoing CEO named Honorary President SeaDragon Limited (NZX:SEA) today announces a number of Director changes as it adds production and supply chain management experience to the Board in preparation for the company’s move into the […]
SeaDragon raises up to $2.5M with convertible loan
/in Portfolio Companies, SeaDragon9:53am, 24 Jun 2015 SEA: NZX and Media Release 24 June 2015 Link here. SeaDragon raises up to $2.5M with convertible loan; signals capital raising Richard Alderton appointed Interim Chief Executive Officer SeaDragon Limited (NZX:SEA) today announces that one of its cornerstone shareholders, BioScience Managers, has agreed to advance the company up to NZ$2.5 million via […]